BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2014 6:38:00 PM | Browse: 765 | Download: 746
Publication Name World Journal of Gastroenterology
Manuscript ID 5844
Country Greece
Received
2013-09-28 15:27
Peer-Review Started
2013-09-29 12:20
To Make the First Decision
2013-12-26 10:54
Return for Revision
2014-01-17 10:00
Revised
2013-10-28 05:32
Second Decision
2014-04-23 08:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-23 10:03
Articles in Press
2014-05-23 11:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-28 16:21
Typeset the Manuscript
2014-08-07 18:31
Publish the Manuscript Online
2014-08-20 18:38
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Topic Highlights
Article Title Corticosteroid-free immunosuppression in liver transplantation: An evidence-based review
Manuscript Source Invited Manuscript
All Author List George Sgourakis and Georgia Dedemadi
Funding Agency and Grant Number
Corresponding Author George Sgourakis, MD, PhD, FACS, 2nd Surgical Department and Surgical Oncology Unit, “Korgialenio-Benakio” Red Cross Hospital, 11 Mantzarou Street, Neo psychiko, 15451 Athens, Greece. ggsgourakis@yahoo.gr
Key Words Meta-analysis; Evidence based; Hepatitis C virus recurrence; Liver transplantation; Steroid withdrawal; Orthotopic liver transplantation
Core Tip Steroid replacement in orthotopic liver transplantation results in fewer cases of overall acute rejection in the corticosteroid free-immunosuppression arm. Tacrolimus monotherapy is a feasible immunosuppression regimen without steroid replacement, although further investigations are needed in view of chronic rejections. No significant differences were noted between the treatment groups in terms of patient and graft survival independently of steroid replacement. Male gender, living donors, cold ischemia times, acute rejection, and early histological recurrence are related to the development of advanced hepatitis. There is sufficient evidence advocating avoidance of the ab initio use of steroids in orthotopic liver transplantation.
Publish Date 2014-08-20 18:38
Citation Sgourakis G, Dedemadi G. Corticosteroid-free immunosuppression in liver transplantation: An evidence-based review. World J Gastroenterol 2014; 20(31): 10703-10714
URL http://www.wjgnet.com/1007-9327/full/v20/i31/10703.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i31.10703
Full Article (PDF) WJG-20-10703.pdf
Full Article (Word) WJG-20-10703.doc
Manuscript File 5844-Review.doc
Answering Reviewers 5844-Answering reviewers.pdf
Copyright License Agreement 5844-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5844-Language certificate.pdf
Peer-review Report 5844-Peer reviews.pdf
Scientific Editor Work List 5844-Scientific editor work list.doc